BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38002998)

  • 1. Base-Excision Repair Mutational Signature in Two Sebaceous Carcinomas of the Eyelid.
    Sangiorgi E; Giannuzzi F; Molinario C; Rapari G; Riccio M; Cuffaro G; Castri F; Benvenuto R; Genuardi M; Massi D; Savino G
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38002998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update.
    Cook BE; Bartley GB
    Ophthalmology; 2001 Nov; 108(11):2088-98; quiz 2099-100, 2121. PubMed ID: 11713084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
    Kwon MJ; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY
    Pathol Res Pract; 2017 Jun; 213(6):654-658. PubMed ID: 28551389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs micrographic surgery versus wide local excision for sebaceous adenocarcinoma of the eyelid : Analysis of a national database.
    Phan K; Loya A
    J Plast Reconstr Aesthet Surg; 2019 Jun; 72(6):1007-1011. PubMed ID: 30894313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collision tumor of sebaceous carcinoma and squamous cell carcinoma of the eyelid: Case report.
    Wang JJ; Lee KF; Chen CY
    Eur J Ophthalmol; 2022 Sep; 32(5):NP55-NP59. PubMed ID: 34011202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma.
    Tetzlaff MT; Singh RR; Seviour EG; Curry JL; Hudgens CW; Bell D; Wimmer DA; Ning J; Czerniak BA; Zhang L; Davies MA; Prieto VG; Broaddus RR; Ram P; Luthra R; Esmaeli B
    J Pathol; 2016 Sep; 240(1):84-95. PubMed ID: 27287813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sebaceous carcinoma of the eyelid--two case reports].
    Zieliński T; Antoszewski B
    Klin Oczna; 2014; 116(2):127-9. PubMed ID: 25345292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of eyelid sebaceous carcinomas.
    Dogru M; Matsuo H; Inoue M; Okubo K; Yamamoto M
    Ophthalmologica; 1997; 211(1):40-3. PubMed ID: 8958530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical 'benign behaviour' of eyelid sebaceous carcinoma.
    Alves S; Silva F; Ferreira M; Cabral J
    BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23125295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UV-independent p53 mutations in sebaceous carcinoma of the eyelid.
    Hussain RM; Matthews JL; Dubovy SR; Thompson JM; Wang G
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):392-5. PubMed ID: 24777261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus.
    Miller CJ; Ioffreda MD; Billingsley EM
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1546-9. PubMed ID: 15606837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sebaceous carcinoma in a 54-year-old Black African man after cancer chemotherapy: a case report.
    Olaofe OO; Adewara BA; Okongwu CC; Abdullahi YO
    J Med Case Rep; 2024 Mar; 18(1):159. PubMed ID: 38500211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid.
    Hata M; Koike I; Omura M; Maegawa J; Ogino I; Inoue T
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):605-11. PubMed ID: 21300468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes.
    Song A; Carter KD; Syed NA; Song J; Nerad JA
    Ophthalmic Plast Reconstr Surg; 2008; 24(3):194-200. PubMed ID: 18520834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line.
    Gu X; Huang Z; Chen J; Luo Y; Ge S; Jia R; Song X; Chai P; Xu S; Fan X
    Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):16. PubMed ID: 38095907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merkel cell carcinoma co-existent with sebaceous carcinoma of the eyelid.
    Tanahashi J; Kashima K; Daa T; Yada N; Fujiwara S; Yokoyama S
    J Cutan Pathol; 2009 Sep; 36(9):983-6. PubMed ID: 19017040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report repairing orbital skin defects using composite flaps after giant eyelid-derived tumor excision and orbital exenteration.
    Fan B; Liu JJ; Wang BF; Sun YJ; Li GY
    Medicine (Baltimore); 2017 Dec; 96(48):e8978. PubMed ID: 29310408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extra-ocular sebaceous carcinoma - A rare case report.
    Sindhura M; Santosh T; Kumar JR; Shankaralingappa A; Pannerselvam NK; Balakrishna P
    Indian J Pathol Microbiol; 2024; 67(1):169-171. PubMed ID: 38358213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases.
    Demirci H; Nelson CC; Shields CL; Eagle RC; Shields JA
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):77-9. PubMed ID: 17237705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
    Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
    Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.